The Fund provides sophisticated investors income and long-term capital appreciation

KUALA LUMPUR, Malaysia, Nov. 11, 2025 /PRNewswire/ — UOB Asset Management (Malaysia) Berhad (UOBAM (Malaysia)) has launched the United Global Premium Opportunity Fund (UGPROF or the Fund), Malaysia’s first global equity wholesale feeder fund that combines high-quality dividend stocks with a single-stock covered call overwriting strategy.

The single-stock covered call overwriting strategy aims to enhance income by selling call options on stocks its own, earning premiums while maintaining exposure to strong companies. This approach seeks to balance income generation with growth potential, making it suitable for investors who are willing to accept the volatility and risks of investing in global equities.

Ms Lim Suet Ling, Chief Executive Officer of UOBAM (Malaysia) said, “As investors face rising concentration risks, macroeconomic uncertainty, inflationary pressures, and trade tensions such as US tariffs, global diversification has never been more critical. Pairing this with an income and growth strategy helps investors capture opportunities and generate returns.

UGPROF offers exposure across major markets including the US, Europe, and Asia, leveraging tech innovation, value sectors, and regional recovery while balancing income generation with long-term growth potential.”

The UGPROF primarily invests in the Fidelity Funds – Global Dividend Plus Fund (Target Fund), managed by Fidelity International. The Fund will be investing a minimum of 90 per cent of its net asset value (NAV) in the Target Fund with the remaining balance in liquid assets which include money market instruments and deposits.

The Target Fund adopts a bottom-up investment process, focusing on companies with strong fundamentals and resilient business models. It prioritises consistent dividend growers over boarder market trends, with key exposures in sectors such as consumer staples, healthcare, financials, and industrials.

The base currency of the Fund is in US Dollar (USD), and it is available in five classes namely, USD Dist Class, Ringgit Dist Class, Ringgit Hedged Dist Class, Singapore Dollar (SGD) Hedged Dist Class, and Australian Dollar (AUD) Hedged Dist Class. The minimum investment amount is US$1,000 for the USD Dist class, RM1,000 for the Ringgit Dist class and Ringgit Hedged Dist class, S$1,000 for the SGD Hedged Dist class, and A$ 1,000 for the AUD Hedged Dist class.

Investors are advised to read and understand the contents of the Fund’s Product Highlights Sheet and Information Memorandum dated 11 November 2025 before investing.

The Fund is available for subscription now at selected distributors. To learn more about the Fund, visit www.uobam.com.my

About UOB Asset Management (Malaysia) Berhad

UOB Asset Management (Malaysia) Berhad (UOBAM (M)) is a subsidiary of Singapore-headquartered UOB Asset Management Ltd (UOBAM) and is part of United Overseas Bank Limited (UOB). UOBAM (M) has held the Capital Markets and Services Licence for fund management in Malaysia under the Capital Market and Services Act since January 1997. In January 2014, UOBAM (M) obtained approval from the Securities Commission of Malaysia to deal in securities restricted to unit trust products.

UOBAM has more than 35 years of experience in managing collective investment schemes and discretionary funds. Headquartered in Singapore, UOBAM has an extensive presence in Asia with regional business and investment offices in Malaysia, Thailand, Brunei, Indonesia, Taiwan region, Japan, and Vietnam. UOBAM has a joint venture with Ping An Fund Management Company Limited. UOBAM and its subsidiaries manage about S$39.9 billion in clients’ assets as of 30 September 2025.

For more information, please visit www.uobam.com.my 

SINGAPORE, Nov. 11, 2025 /PRNewswire/ — Moutai Singapore Open came to a successful conclusion on November 9th. After four days of closely fought rounds, Japanese Yosuke Asaji emerged as champion with a total score of nineteen-under-par 269. The tournament was followed by a gala hosted by Moutai, which served as a vibrant platform for professional networking and cultural exchange. The banquet was attended by an audience of distinguished guests, comprising Asian Tour representatives, leading business figures from across the globe, and media representatives.

Zhang Xu, Deputy General Manager of Kweichow Moutai Co.,Ltd. and Chairman of Kweichow Moutai Sales Co., Ltd. said in a speech at the event: “The Chinese culture carried by Moutai is the core force for us to go global. Here in Singapore, a confluence of diverse cultures, we are delighted to use golf as a medium to allow the world to more deeply appreciate Moutai’s craftsmanship and cultural heritage.”

Cho Minn Thant, Chief Executive Officer of the Asian Tour, highlighted Moutai’s footprint across Japan, Hong Kong SAR and Singapore, and its role as the Asian Tour’s Official Baijiu Partner. He said the partnership has flourished this season and voiced confidence in its future, commending Moutai’s dedication to quality as the standard the Tour strives for worldwide.

In the Moutai tasting space, guests savored the mellow flavor and unique distilling techniques of Moutai. “The aroma and taste of Moutai are very unique, quite different from any other liquor I’ve had before. The events were also fantastic, it truly deserves its reputation as a model brand of Chinese baijiu.” Commented a Singaporean player. Meanwhile, shows with Chinese artistic connotations and those brimming with Southeast Asian charm were presented on stage, along with music and visual arts to create a unique and culture-rich atmosphere.

Following the conclusion of the 2025 Moutai Singapore Open, the “Moutai Night” gala took center stage. It became a powerful demonstration of Moutai’s global brand vision: using culture as a bridge, and taste as its language, to connect with the world.

SUZHOU, China, Nov. 10, 2025 /PRNewswire/ — A news report from Xinhua Finance:

The 2025 Automotive Technology and Equipment Development Forum was held in Suzhou from November 6 to 8. Framed around the theme “Equipment as the Foundation, Technology as the Path Forward”, the event was jointly organized by the Equipment Industry Development Center (EIDC) under the Ministry of Industry and Information Technology, the Suzhou Municipal People’s Government, and China Automotive Engineering Research Institute Co. Ltd. (CAERI). The forum served as a venue for policy briefings, technical exchanges, showcases of applied results, and matchmaking sessions—with the aim of transitioning the auto sector toward closer integration of manufacturing equipment with intelligent technologies and building an industry ecosystem that is open, partnership-based, and aimed at shared gains.

During the forum, the EIDC released the “China Automotive Industry and Technology Development Report (2025)”. The report said China’s automotive industry has posted notable gains in recent years and has been a steadying factor for the broader industrial economy. From January to September this year, nationwide automobile output and sales came in at 24.333 million and 24.363 million units, respectively, up 13.3% and 12.9% year-on-year. The electric-vehicle segment stood out in particular, with production reaching 11.243 million units and sales 11.228 million units over the same period—more than 35% higher and accounting for 46.1% of all new passenger- and commercial-vehicle combined sales.

Looking ahead to the future of the automotive industry, several industry experts at the forum offered systematic recommendations. Su Bo, Director of the National Expert Committee on Intelligent Manufacturing and former Vice Minister of the Ministry of Industry and Information Technology, said China needs to channel resources toward clearing core technology chokepoints, notably automotive-grade chips, high-safety solid-state batteries, and in-vehicle operating systems. He added that China should make fuller use of national-level science and technology platforms, including the National Innovation Center of Intelligent and Connected Vehicles, to make sure it keeps control over the pace and direction of technology upgrades.

The forum also saw the launch of a series of initiatives aimed at strengthening the global competitiveness of China’s auto industry. These include the “Standards Lead the Way, Quality Drives the Future” campaign, which seeks to lift the international profile of Chinese auto brands through tighter and more export-ready quality benchmarks; the “China Chip” Joint Research Lab, set up to reinforce China’s semiconductor capabilities for intelligent and connected electric vehicles; the “Upgrading Automotive Manufacturing with Domestic High-End Equipment” program, designed to raise quality and efficiency through the use of domestically produced advanced machinery; and the “15^th Five-Year Plan Synergy for Automotive Technology and Equipment” initiative, which is intended to keep future advances in vehicle technology and supporting industrial equipment on the same track. Taken together, these measures are expected to add momentum to priority areas such as quality, chips, and high-end equipment—key drivers shaping the industry’s future. 

RAICHUR, India, Nov. 11, 2025 /PRNewswire/ — Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), has been awarded the prestigious Gold Medal by EcoVadis, the world’s most trusted provider of business sustainability ratings.

The company achieved an exceptional score of 82/100, placing it in the 98th percentile globally among 130,000 + companies evaluated by EcoVadis. This performance underscores our industry-leading Environmental, Social and Governance (ESG) practices and reflects our long-term commitment to building a responsible, resilient, and sustainable pharmaceutical enterprise.

EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for sustainable business operations.

Speaking on this milestone, Mr. Keshav Bhutada, ED & CEO of Shilpa Pharma Lifesciences emphasized that “Sustainability and innovation are integral to Shilpa’s CDMO growth strategy to work with global innovator companies for their New chemical Entity programs. The EcoVadis Gold Medal is a testimony to our relentless efforts toward responsible manufacturing, ethical governance, and inclusive growth that creates enduring value for patients and partners. We look forward to work with more global innovator companies”

This achievement further strengthens Shilpa’s credentials with global customers, investors, and partners, reinforcing their positioning as a trusted global CDMO partner with sustainability at the core of their operations.

About Shilpa Medicare Limited

Shilpa Medicare Limited (BSE: 530549 | NSE: SHILPAMED) is a leading Indian pharmaceutical company focused on the development, manufacture, and marketing of APIs, formulations, and biologics across oncology, infectious diseases, and specialty segments. With expertise in complex generics, novel drug delivery systems, and CDMO services, Shilpa serves patients in over 80 countries. For more information, visit www.vbshilpa.com

Forward-Looking Statement Disclaimer

This document contains forward-looking statements describing the Company’s objectives, plans, and expectations for future performance. Actual results may differ materially due to risks and uncertainties including regulatory approvals, clinical outcomes, market conditions, and competitive developments. Shilpa Medicare undertakes no obligation to update forward-looking statements to reflect subsequent events or circumstances.